Seegene Inc
KOSDAQ:096530
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Seegene Inc
Other Current Assets
Seegene Inc
Other Current Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Current Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
S
|
Seegene Inc
KOSDAQ:096530
|
Other Current Assets
₩20.8B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
6%
|
CAGR 10-Years
20%
|
|
|
Celltrion Inc
KRX:068270
|
Other Current Assets
₩165B
|
CAGR 3-Years
43%
|
CAGR 5-Years
41%
|
CAGR 10-Years
20%
|
|
|
V
|
Voronoi Inc
KOSDAQ:310210
|
Other Current Assets
₩2.3B
|
CAGR 3-Years
76%
|
CAGR 5-Years
33%
|
CAGR 10-Years
N/A
|
|
|
Alteogen Inc
KOSDAQ:196170
|
Other Current Assets
₩6.9B
|
CAGR 3-Years
0%
|
CAGR 5-Years
44%
|
CAGR 10-Years
38%
|
|
|
A
|
ABL Bio Inc
KOSDAQ:298380
|
Other Current Assets
₩1.5B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
62%
|
CAGR 10-Years
N/A
|
|
|
D
|
DND PharmaTech Inc
KOSDAQ:347850
|
Other Current Assets
₩4.1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Seegene Inc
Glance View
Seegene, Inc. engages in the manufacturing and distributing of molecular diagnostics and reagents. The company is headquartered in Seoul, Seoul. The company went IPO on 2010-09-10. The firm mainly provides infectious pathogens inspection products, including allergic respiratory pathogens, sexually transmitted diseases pathogens, human papilloma virus (HPV) and other inspection products, drug resistance inspection products, single nucleotide polymorphisms (SNP) inspection products, as well as somatic mutation cancer inspection products. In addition, it is involved in the provision of automatic real-time detection instruments. The firm provides its products under the brand names of Seeplex, Anyplex and Magicplex. The firm distributes its products within domestic market and to overseas markets.
See Also
What is Seegene Inc's Other Current Assets?
Other Current Assets
20.8B
KRW
Based on the financial report for Dec 31, 2025, Seegene Inc's Other Current Assets amounts to 20.8B KRW.
What is Seegene Inc's Other Current Assets growth rate?
Other Current Assets CAGR 10Y
20%
Over the last year, the Other Current Assets growth was 22%. The average annual Other Current Assets growth rates for Seegene Inc have been -2% over the past three years , 6% over the past five years , and 20% over the past ten years .
